$3.65
0.164.58%
At close: -
$3.67
0.020.55%
After Hours: Apr 11, 7:42 PM EDT
Comments
Loading...
Amylyx Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AMLX | Benzinga
Amylyx Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.500
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$87.37M
Analyze the earnings history of Amylyx Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharma | -$0.12 | -$0.50 | — | — | $88.64M | — | — | — | 05/08/2025 | Get Alert |
| AMLX | Amylyx Pharma | $0.07 | -$0.59 | -$0.55 | 6.78% | $108.45M | — | -$665.00K | — | 03/04/2025 | Get Alert |
| AMLX | Amylyx Pharma | $0.30 | -$0.71 | -$0.53 | 25.35% | $102.69M | — | $416.00K | — | 11/07/2024 | Get Alert |
| AMLX | Amylyx Pharma | $0.31 | -$0.73 | -$0.73 | 0.00% | $98.22M | $10.66M | -$1.20M | -111.29% | 08/08/2024 | Get Alert |
| AMLX | Amylyx Pharma | $0.02 | -$0.01 | -$0.12 | -1100.00% | $71.43M | $98.35M | $88.64M | -9.87% | 05/09/2024 | Get Alert |
| AMLX | Amylyx Pharma | -$0.65 | $0.23 | $0.07 | -69.57% | $21.89M | $106.96M | $108.45M | 1.39% | 02/22/2024 | Get Alert |
| AMLX | Amylyx Pharma | -$0.92 | $0.44 | $0.30 | -31.82% | $345.00K | $114.26M | $102.69M | -10.12% | 11/09/2023 | Get Alert |
| AMLX | Amylyx Pharma | -$0.93 | $0.10 | $0.31 | 210.00% | $0.00 | $92.14M | $98.22M | 6.59% | 08/10/2023 | Get Alert |
| AMLX | Amylyx Pharma | -$0.93 | — | $0.02 | — | $0.00 | $58.99M | $71.43M | 21.08% | 05/11/2023 | Get Alert |
| AMLX | Amylyx Pharma | -$4.10 | -$0.82 | -$0.65 | 20.73% | $0.00 | $4.72M | $21.89M | 363.67% | 03/13/2023 | Get Alert |
| AMLX | Amylyx Pharma | — | -$0.97 | -$0.92 | 5.15% | — | $80.00K | $345.00K | 331.25% | 11/10/2022 | Get Alert |
| AMLX | Amylyx Pharma | -$3.41 | -$0.87 | -$0.93 | -6.90% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| AMLX | Amylyx Pharma | -$2.33 | — | -$0.93 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
Amylyx Pharmaceuticals (AMLX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-04 | $-0.55 | $-0.59 | 6.78 % |
| Q3 | 2024-11-07 | $-0.53 | $-0.71 | 25.4 % |
| Q2 | 2024-08-08 | $-0.73 | $-0.73 | 0.00 % |
| Q1 | 2024-05-09 | $-0.12 | $-0.01 | -1100.0 % |
Amylyx Pharmaceuticals (AMLX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-08 | $-1.20M | $10.66M | -111.3 % |
| Q1 | 2024-05-09 | $88.64M | $98.35M | -9.87 % |
| Q4 | 2024-02-22 | $108.45M | $106.96M | 1.39 % |
| Q3 | 2023-11-09 | $102.69M | $114.26M | -10.1 % |
FAQ
When is Amylyx Pharmaceuticals (NASDAQ:AMLX) reporting earnings?
Amylyx Pharmaceuticals (AMLX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 4, 2025 for Q4.
What were the latest earnings per share (EPS) for Amylyx Pharmaceuticals (NASDAQ:AMLX)?
The Actual EPS was $-0.55, which beat the estimate of $-0.59.
What were Amylyx Pharmaceuticals’s (NASDAQ:AMLX) revenues?
The Actual Revenue was $-665K, which missed the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.